Drugs / Systane Ultra Multidose
last change Jun 2021 re-read 2 minutes ago

Systane Ultra Multidose

Developed for
dry eye syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04393441 Comparator Jun 2020 → Jun 2021 dry eye syndrome Allergan Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Systane Ultra Multidose ClinicalTrials.gov intervention name — accepted as the source's own label NCT04393441
Route Topical Topical eye drops” NCT04393441